 | • レポートコード：GIR-107A12619 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、前立腺がん診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前立腺がん診断の種類別市場規模（腫瘍バイオマーカー検査、画像診断、生検、その他）、用途別市場規模（55歳以下、55〜75歳、75歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・前立腺がん診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：OPKO、Genomic Health、Abbott、Beckman Coulter、Siemens Healthcare、bioMeriux、Roche、MDx Health、DiaSorin、Myriad Genetics、Ambry Genetics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：腫瘍バイオマーカー検査、画像診断、生検、その他 ・用途別分析2016年-2026年：55歳以下、55〜75歳、75歳以上 ・前立腺がん診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・前立腺がん診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・前立腺がん診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・前立腺がん診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・前立腺がん診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Prostate Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Prostate Cancer Diagnostics size is estimated to be USD 17210 million in 2026 from USD 12880 million in 2020, with a change XX% between 2020 and 2021. The global Prostate Cancer Diagnostics market size is expected to grow at a CAGR of 7.5% for the next five years.
Market segmentation
Prostate Cancer Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tumor Biomarker Tests
Imaging
Biopsy
Other
Market segment by Application, can be divided into
Age Below 55
Age 55-75
Age Above 75
Market segment by players, this report covers
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer Diagnostics, with revenue, gross margin and global market share of Prostate Cancer Diagnostics from 2019 to 2021.
Chapter 3, the Prostate Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Prostate Cancer Diagnostics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Prostate Cancer Diagnostics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnostics
1.2 Classification of Prostate Cancer Diagnostics by Type
1.2.1 Overview: Global Prostate Cancer Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type in 2020
1.2.3 Tumor Biomarker Tests
1.2.4 Imaging
1.2.5 Biopsy
1.2.6 Other
1.3 Global Prostate Cancer Diagnostics Market by Application
1.3.1 Overview: Global Prostate Cancer Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Global Prostate Cancer Diagnostics Market Size & Forecast
1.5 Global Prostate Cancer Diagnostics Market Size and Forecast by Region
1.5.1 Global Prostate Cancer Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate Cancer Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Prostate Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Prostate Cancer Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate Cancer Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Diagnostics Market Drivers
1.6.2 Prostate Cancer Diagnostics Market Restraints
1.6.3 Prostate Cancer Diagnostics Trends Analysis
2 Company Profiles
2.1 OPKO
2.1.1 OPKO Details
2.1.2 OPKO Major Business
2.1.3 OPKO Prostate Cancer Diagnostics Product and Solutions
2.1.4 OPKO Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 OPKO Recent Developments and Future Plans
2.2 Genomic Health
2.2.1 Genomic Health Details
2.2.2 Genomic Health Major Business
2.2.3 Genomic Health Prostate Cancer Diagnostics Product and Solutions
2.2.4 Genomic Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Genomic Health Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Prostate Cancer Diagnostics Product and Solutions
2.3.4 Abbott Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
2.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 Siemens Healthcare
2.5.1 Siemens Healthcare Details
2.5.2 Siemens Healthcare Major Business
2.5.3 Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
2.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Siemens Healthcare Recent Developments and Future Plans
2.6 bioMeriux
2.6.1 bioMeriux Details
2.6.2 bioMeriux Major Business
2.6.3 bioMeriux Prostate Cancer Diagnostics Product and Solutions
2.6.4 bioMeriux Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 bioMeriux Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Prostate Cancer Diagnostics Product and Solutions
2.7.4 Roche Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Roche Recent Developments and Future Plans
2.8 MDx Health
2.8.1 MDx Health Details
2.8.2 MDx Health Major Business
2.8.3 MDx Health Prostate Cancer Diagnostics Product and Solutions
2.8.4 MDx Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 MDx Health Recent Developments and Future Plans
2.9 DiaSorin
2.9.1 DiaSorin Details
2.9.2 DiaSorin Major Business
2.9.3 DiaSorin Prostate Cancer Diagnostics Product and Solutions
2.9.4 DiaSorin Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 DiaSorin Recent Developments and Future Plans
2.10 Myriad Genetics
2.10.1 Myriad Genetics Details
2.10.2 Myriad Genetics Major Business
2.10.3 Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
2.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Myriad Genetics Recent Developments and Future Plans
2.11 Ambry Genetics
2.11.1 Ambry Genetics Details
2.11.2 Ambry Genetics Major Business
2.11.3 Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
2.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Ambry Genetics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate Cancer Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Cancer Diagnostics Players Market Share
3.2.2 Top 10 Prostate Cancer Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate Cancer Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate Cancer Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Prostate Cancer Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate Cancer Diagnostics Revenue by Type (2016-2026)
6.2 North America Prostate Cancer Diagnostics Revenue by Application (2016-2026)
6.3 North America Prostate Cancer Diagnostics Market Size by Country
6.3.1 North America Prostate Cancer Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Cancer Diagnostics Revenue by Type (2016-2026)
7.2 Europe Prostate Cancer Diagnostics Revenue by Application (2016-2026)
7.3 Europe Prostate Cancer Diagnostics Market Size by Country
7.3.1 Europe Prostate Cancer Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Cancer Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate Cancer Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2016-2026)
8.3.2 China Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate Cancer Diagnostics Revenue by Type (2016-2026)
9.2 South America Prostate Cancer Diagnostics Revenue by Application (2016-2026)
9.3 South America Prostate Cancer Diagnostics Market Size by Country
9.3.1 South America Prostate Cancer Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate Cancer Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Prostate Cancer Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate Cancer Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate Cancer Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate Cancer Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. OPKO Corporate Information, Head Office, and Major Competitors
Table 7. OPKO Major Business
Table 8. OPKO Prostate Cancer Diagnostics Product and Solutions
Table 9. OPKO Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 11. Genomic Health Major Business
Table 12. Genomic Health Prostate Cancer Diagnostics Product and Solutions
Table 13. Genomic Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott Prostate Cancer Diagnostics Product and Solutions
Table 17. Abbott Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter Major Business
Table 20. Beckman Coulter Prostate Cancer Diagnostics Product and Solutions
Table 21. Beckman Coulter Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 23. Siemens Healthcare Major Business
Table 24. Siemens Healthcare Prostate Cancer Diagnostics Product and Solutions
Table 25. Siemens Healthcare Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. bioMeriux Corporate Information, Head Office, and Major Competitors
Table 27. bioMeriux Major Business
Table 28. bioMeriux Prostate Cancer Diagnostics Product and Solutions
Table 29. bioMeriux Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Roche Corporate Information, Head Office, and Major Competitors
Table 31. Roche Major Business
Table 32. Roche Prostate Cancer Diagnostics Product and Solutions
Table 33. Roche Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. MDx Health Corporate Information, Head Office, and Major Competitors
Table 35. MDx Health Major Business
Table 36. MDx Health Prostate Cancer Diagnostics Product and Solutions
Table 37. MDx Health Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 39. DiaSorin Major Business
Table 40. DiaSorin Prostate Cancer Diagnostics Product and Solutions
Table 41. DiaSorin Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 43. Myriad Genetics Major Business
Table 44. Myriad Genetics Prostate Cancer Diagnostics Product and Solutions
Table 45. Myriad Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Ambry Genetics Corporate Information, Head Office, and Major Competitors
Table 47. Ambry Genetics Major Business
Table 48. Ambry Genetics Prostate Cancer Diagnostics Product and Solutions
Table 49. Ambry Genetics Prostate Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Prostate Cancer Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 51. Global Prostate Cancer Diagnostics Revenue Share by Players (2019-2021)
Table 52. Breakdown of Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Prostate Cancer Diagnostics Players Head Office, Products and Services Provided
Table 54. Prostate Cancer Diagnostics Mergers & Acquisitions in the Past Five Years
Table 55. Prostate Cancer Diagnostics New Entrants and Expansion Plans
Table 56. Global Prostate Cancer Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 57. Global Prostate Cancer Diagnostics Revenue Share by Type (2016-2021)
Table 58. Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026)
Table 59. Global Prostate Cancer Diagnostics Revenue by Application (2016-2021)
Table 60. Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026)
Table 61. North America Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Prostate Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Prostate Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Prostate Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Prostate Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Prostate Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Prostate Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Prostate Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Prostate Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Prostate Cancer Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Prostate Cancer Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Prostate Cancer Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Prostate Cancer Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate Cancer Diagnostics Picture
Figure 2. Global Prostate Cancer Diagnostics Revenue Market Share by Type in 2020
Figure 3. Tumor Biomarker Tests
Figure 4. Imaging
Figure 5. Biopsy
Figure 6. Other
Figure 7. Prostate Cancer Diagnostics Revenue Market Share by Application in 2020
Figure 8. Age Below 55 Picture
Figure 9. Age 55-75 Picture
Figure 10. Age Above 75 Picture
Figure 11. Global Prostate Cancer Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Prostate Cancer Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 14. Global Prostate Cancer Diagnostics Revenue Market Share by Region in 2020
Figure 15. North America Prostate Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Prostate Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Prostate Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Prostate Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Prostate Cancer Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Prostate Cancer Diagnostics Market Drivers
Figure 21. Prostate Cancer Diagnostics Market Restraints
Figure 22. Prostate Cancer Diagnostics Market Trends
Figure 23. OPKO Recent Developments and Future Plans
Figure 24. Genomic Health Recent Developments and Future Plans
Figure 25. Abbott Recent Developments and Future Plans
Figure 26. Beckman Coulter Recent Developments and Future Plans
Figure 27. Siemens Healthcare Recent Developments and Future Plans
Figure 28. bioMeriux Recent Developments and Future Plans
Figure 29. Roche Recent Developments and Future Plans
Figure 30. MDx Health Recent Developments and Future Plans
Figure 31. DiaSorin Recent Developments and Future Plans
Figure 32. Myriad Genetics Recent Developments and Future Plans
Figure 33. Ambry Genetics Recent Developments and Future Plans
Figure 34. Global Prostate Cancer Diagnostics Revenue Share by Players in 2020
Figure 35. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Prostate Cancer Diagnostics Revenue Market Share in 2020
Figure 37. Global Top 10 Players Prostate Cancer Diagnostics Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Prostate Cancer Diagnostics Revenue Share by Type in 2020
Figure 40. Global Prostate Cancer Diagnostics Market Share Forecast by Type (2021-2026)
Figure 41. Global Prostate Cancer Diagnostics Revenue Share by Application in 2020
Figure 42. Global Prostate Cancer Diagnostics Market Share Forecast by Application (2021-2026)
Figure 43. North America Prostate Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 44. North America Prostate Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 45. North America Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 46. United States Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Prostate Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 50. Europe Prostate Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 51. Europe Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 52. Germany Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Prostate Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Prostate Cancer Diagnostics Revenue Market Share by Region (2016-2026)
Figure 60. China Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Prostate Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 67. South America Prostate Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 68. South America Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Prostate Cancer Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の前立腺がん治療薬市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の新たながん診断市場 2021：企業別、地域別、種類・用途別 The Emerging Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の肝臓がん診断市場 2021：企業別、地域別、種類・用途別 The Liver Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界のがんバイオマーカー市場 2021：企業別、地域別、種類・用途別 The Cancer Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界の迅速がん検査キット市場 2021：企業別、地域別、種類・用途別 The Rapid Cancer Tests Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…